Overview

Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke

Status:
RECRUITING
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
A prospective, single-center study would be carried out in the Neurology Department of the University Hospital "Dr. José Eleuterio González" in order to analyze the effect of cerebrolysin on the blood-brain-barrier in patients with ischemic stroke with personal history of type-2 diabetes
Phase:
PHASE4
Details
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Collaborator:
Ever Neuro Pharma GmbH
Treatments:
cerebrolysin